Aaron Nagiel
Ophthalmology · Ventura, CANPI 1669771879
Payments from drug & device makers
What this record shows
This record is dominated by grants: $90,000 of the $132,615 with a category attached, or 67.9%. Alcon Research LLC accounts for 67.9% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $90,509, more than ten times the $498 reported in 2019. Among ophthalmology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 43 payments — averaging $3084.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon Research LLC$90K
- Ultragenyx Pharmaceutical Inc.$24K
- Janssen Research & Development, LLC$9K
- Novartis Pharma AG$6K
- Johnson & Johnson$2K
- Regeneron Healthcare Solutions, Inc.$466
- plus $1K from 9 others
Across 67 payments — averaging $15,079 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$770K
- Spark Therapeutics, Inc.$236K
- Biogen$4K
What the payments were for
- Consulting fees$16,36512%
- Speaking & faculty fees$19,25015%
- Grants$90,00068%
- Travel & lodging$5,0704%
- Food & beverage$1,9241%
- Education$60%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon Research LLC | 1 | $90,000 |
| Ultragenyx Pharmaceutical Inc. | 8 | $24,320 |
| Janssen Research & Development, LLC | 5 | $8,523 |
| Novartis Pharma AG | 1 | $6,150 |
| Johnson & Johnson | 1 | $1,815 |
| Regeneron Healthcare Solutions, Inc. | 5 | $466 |
| Spark Therapeutics, Inc. | 6 | $360 |
| Carl Zeiss Meditec USA, Inc. | 4 | $217 |
| AbbVie | 2 | $214 |
| Alcon | 2 | $204 |
| Carl Zeiss Meditec, Inc. | 3 | $148 |
| Bausch & Lomb Americas Inc. | 1 | $128 |
| Regeneron | 1 | $42 |
| Astellas Pharma US Inc | 1 | $22 |
| Travere Therapeutics, Inc. | 2 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$132,615 in reported general payments places this provider in the 95th percentile of 2,513 ophthalmology providers in California.
Other ophthalmology in Ventura
- Daniel SchwartzSan Francisco$8M
- Michael BerlinWest Hollywood$5.7M
- Gilbert KlimanMenlo Park$1.5M
- Kuldev SinghStanford$1.5M
- Raymond DouglasBeverly Hills$1.3M
- John AffeldtLoma Linda$1.1M
- Srinivas SaddaPasadena$1M
- Sheri RowenNewport Beach$1M
- Savak TeymoorianLaguna Hills$955K
- Andrew MoshfeghiLos Angeles$895K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.